Trials of semaglutide in patients with Alzheimer’s and CagriSema in obese patients diabetes could give investors reason to be ...
Europe's STOXX 600 was slightly down at the start of a holiday-shortened week, after clocking its steepest weekly drop since ...
As of 11:05 a.m. ET, Novo Nordisk stock is down a disheartening 20.8%, while both Lilly and Viking stocks are up 4.4% apiece.
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/15.BB0BQA4q.js ...
The treatment, called CagriSema, led patients to lose 20% of their weight at 68 weeks in a late-stage study when looking at ...
Las acciones de la farmaceútuca danesa Novo Nordisk A/S registraron la mayor caída de su historia tras informar resultados ...
2don MSN
Evan David Seigerman, BMO managing director, joins 'Fast Money' to discuss Novo sinking on its obesity drug data.
Stocks traded sharply higher Friday as a key inflation measure came in lower than expected. The Dow Jones Industrial Average ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback